secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-08-17T20:19:58+00:00
Accession:  0001193125-26-354096
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health appoints Teresa Heitsenrether to board; Larry Robbins resigns
------------------------------------------------------------------------

- Larry Robbins resigned from CVS Health board effective Aug 13, 2026; no disagreement cited.
- Teresa Heitsenrether, JPMorgan Chief Data & Analytics Officer, appointed effective Nov 18, 2026.
- Heitsenrether brings 40 years financial services experience; deemed independent under NYSE rules.
- Robbins served since 2024 on Audit and Public Policy committees; departure after two years.
- Robbins (Glenview CEO) cited improved financial performance and balance sheet repair during tenure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000119312526354096/0001193125-26-354096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000119312526354096/d129035d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-354096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer